(Washington, DC – May 19, 2016) –  Galileo Analytics Co-Founder and CEO Simon Fitall will join a group of prestigious speakers at next week’s MD Bio+Tech16 conference in Bethesda, Maryland.

Fitall’s presentation will address the need to combine clinical care and out-patient data sources to truly understand health and disease. In addition, he will discuss the promise of tools, such as Galileo Cosmos, which enables researchers to dynamically explore these new, large, combined data sets to learn how to interpret these new data sources and extract the maximum value.

The Promise + Limits of Big Data

May 23, 2016

2:15 pm EDT



Katie Merrell, Senior Research Scientist, Social & Scientific Systems, Inc.


Simon Fitall, Co-Founder and Chief Executive Officer, Galileo Analytics

Dr. Nick van Terheyden, Chief Medical Officer, Dell Healthcare and Life Sciences

Michael Wasser, Founder and Chief Executive Officer, BloomAPI


About MD Bio+Tech16

MD Bio+Tech 16 is sponsored by the Tech Council of Maryland, which aims to build stronger technology and life science communities in Maryland by nurturing a healthy and vibrant environment where members can connect and prosper. Bio+Tech16 supports TCM’s mission by providing a forum for life science and technology professionals to exchange ideas and explore partnerships. In addition, Bio+Tech16 support TCM’s vision of positioning Maryland as a top-three innovation economy for technology and life sciences as well as the next “Silicon Valley” for these two industries.

For more information about MD Bio+Tech16, visit: http://bio-techconference.com



About Admin

Anna McCollister-Slipp is co-founder of Galileo Analytics, a Visual Data Exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data. In addition, she is the Chief Advocate for Participatory Research at the Scripps Translational Science Institute, where she is charged with bringing the expertise of patients, caregivers and community physicians into the design of health research. Anna’s passion for innovation in health data research is rooted in her personal experiences living with type 1 diabetes. As an entrepreneur and advocate, she speaks frequently about the promise of digital health, the imperative for patient data access and the need for improved outcomes measures for chronic disease. Anna serves on a number of government and private committees and boards aimed at promoting innovative ways to better understand, manage and treat complex health conditions, such as diabetes.

%d bloggers like this: